1w
12h
Shift work sleep disorder - PubMed
Source : https://pubmed.ncbi.nlm.nih.gov/39864934/
Shift work sleep disorder (SWSD) is a circadian rhythm sleep-wake disorders affecting individuals who work in nonstandard hours, particularly night shifts. It manifests as difficulty sleeping during the day and...
Shift work sleep disorder stems from circadian misalignment causing insomnia and sleepiness; diagnosis uses sleep patterns, and management includes scheduling, light therapy, melatonin, and hygiene.
1w
Differences in clinical features between current smokers and former smokers with OSA: a cross-sectional study - PubMed
Source : https://pubmed.ncbi.nlm.nih.gov/41266523/
Smoking is both a cause of obstructive sleep apnea (OSA) and is an important reason for its rising prevalence. However, there is a lack of studies predicting smoking cessation specifically...
Cross-sectional analysis of 504 OSA patients showed former smokers were older with more severe OSA. Age, disease duration, BMI, AHI, comorbidities, and lower MSaO2 influenced smoking cessation and interacted with metabolic conditions.
2w
Insomnia as a risk factor for temporomandibular disorders: a nationwide population-based cohort study - PubMed
Source : https://pubmed.ncbi.nlm.nih.gov/41243088/
Clinically diagnosed insomnia was found to be associated with an increased risk of developing TMD. However, as this study was based on the NHIS database, causality cannot be definitively established....
Nationwide matched-cohort analysis showed clinically diagnosed insomnia significantly increased temporomandibular disorder incidence. Adjusted models confirmed a 36% higher TMD risk, supporting the importance of integrating sleep assessments in TMD evaluation and management.
2w
Advances in lung health and sleep medicine: Key highlights from CHEST 2025
At CHEST 2025 in Chicago, pulmonology experts shared new insights in asthma, COPD, interstitial lung disease, pulmonary hypertension, and sleep medicine. Dr. Sandhya Khurana highlighted emerging asthma data—such as imaging-based reductions in mucus plugging and outcomes in severe asthma with nasal polyps—while also discussing the future of nanobody therapeutics. Dr. Cosmo Fowler reviewed GLP-1 RA–linked survival benefits in OSA.
Share your thoughts